Literature DB >> 18491205

Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.

Georgios Kalambokis1, Areti Theodorou1, Paraskevi Kosta2, Epameinondas V Tsianos3.   

Abstract

Pyomyositis is infrequently reported in patients with multiple myeloma. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is emerging as an important cause of soft tissue infections, including pyomyositis. Here, we report on the first case of CA-MRSA pyomyositis in a patient with multiple myeloma and review the relevant literature.

Entities:  

Mesh：

Year:  2008        PMID： 18491205     DOI： 10.1007/s12185-008-0100-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  25 in total

1.  Pyomyositis caused by methicillin-resistant Staphylococcus aureus.

Authors:  Maria E Ruiz; Seife Yohannes; Christopher G Wladyka
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

2.  Community acquired MRSA in Europe.

Authors:  Tristan Ferry; Jerome Etienne
Journal:  BMJ       Date:  2007-10-23

3.  Infections complicating multiple myeloma and chronic lymphocytic leukemia.

Authors:  J J Twomey
Journal:  Arch Intern Med       Date:  1973-10

4.  [Pyomyositis: retrospective review in a third-level hospital in the north of Spain].

Authors:  Marta Martín-Millán; Carmen García-Ibarbia; Manuel Gutiérrez-Cuadra; Mar Gutiérrez-Santiago; Marta Fernández-Sampedro; Jesús González-Macías; José L Hernández-Hernández
Journal:  Enferm Infecc Microbiol Clin       Date:  2006-03       Impact factor: 1.731

5.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis in an intravenous drug user.

Authors:  A Fowler; A Mackay
Journal:  J Med Microbiol       Date:  2006-01       Impact factor: 2.472

7.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

8.  Clinical characteristics of Staphylococcal pyomyositis.

Authors:  Hueng-Chuen Fan; Wen-Tsung Lo; Mong-Ling Chu; Chih-Chien Wang
Journal:  J Microbiol Immunol Infect       Date:  2002-06       Impact factor: 4.399

9.  Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  S L Davis; M B Perri; S M Donabedian; C Manierski; A Singh; D Vager; N Z Haque; K Speirs; R R Muder; B Robinson-Dunn; M K Hayden; M J Zervos
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

10.  Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.

Authors:  Anne Tristan; Michele Bes; Helene Meugnier; Gerard Lina; Bülent Bozdogan; Patrice Courvalin; Marie-Elisabeth Reverdy; Mark C Enright; François Vandenesch; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.